Learn More
Medchemexpress LLC 8-(4-(trifluoromethyl)phenyl)-N-(1,1,1-trifluoropropan-2-yl)-dihydro-1,7-naphthyridine carboxamide | 1470018-52-0 | >98.0% | 417.3 g·mol^-1 | C19H17F6N3O | 100 MG

Supplier: Medchemexpress LLC HY104059100MG
AMG2850 is a selective, orally bioavailable antagonist of the transient receptor potential melastatin 8 (TRPM8) ion channel. Synthesized at Amgen and characterized in peer-reviewed literature, it inhibits menthol- and cold-induced TRPM8 activation and is used as a research reagent in preclinical pharmacology and TRP channel studies.
- Potent inhibition of menthol- and cold-induced TRPM8 activation.
- High selectivity over other TRP channels.
- Orally bioavailable pharmacokinetic profile suitable for in vivo studies.
- Reported high chemical purity, suitable for research applications.
- Used and validated in peer-reviewed preclinical studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.